Diabetes Center of the Southwest

Diabetes Center of the Southwest is a clinical research facility and medical clinic based in Midland, Texas, with additional operations in San Antonio. The center specializes in the treatment and clinical study of diabetes mellitus, obesity, hypertension, and related metabolic and endocrine disorders. It serves as a prominent site for Phase 2 and Phase 3 clinical trials, collaborating with major pharmaceutical companies such as Novo Nordisk, Daiichi Sankyo, and AstraZeneca to evaluate novel therapeutic agents. Led by experienced endocrinologists and clinical researchers, the center provides comprehensive patient care, diabetes education, and access to investigational treatments for metabolic health.